Thomas Gregory Moore - Net Worth and Insider Trading

Thomas Gregory Moore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Gregory Moore owns 2 companies in total, including Avenue Therapeutics Inc (ATXI) , and Akorn Inc (AKRXQ) .

Click here to see the complete history of Thomas Gregory Moore’s form 4 insider trades.

Insider Ownership Summary of Thomas Gregory Moore

Ticker	Comapny	Transaction Date	Type of Owner
ATXI	Avenue Therapeutics Inc	2019-04-30	director
AKRXQ	Akorn Inc	2019-01-24	director

Thomas Gregory Moore Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Gregory Moore Ownership Network

Ownership Network List of Thomas Gregory Moore

No Data

Ownership Network Relation of Thomas Gregory Moore

Thomas Gregory Moore Owned Company Details

What does Avenue Therapeutics Inc do?

Who are the key executives at Avenue Therapeutics Inc?

Thomas Gregory Moore is the director of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .

Avenue Therapeutics Inc (ATXI) Insider Trades Summary

Over the past 18 months, Thomas Gregory Moore made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net purchase of 439 shares made by Jay D Kranzler , a net sale of 617,000 shares made by , and a net purchase of 418,410 shares made by Fortress Biotech, Inc. .

In summary, during the past 3 months, insiders sold 84 shares of Avenue Therapeutics Inc (ATXI) in total and bought 500 shares, with a net purchase of 416 shares. During the past 18 months, 8,311 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,728 shares were bought by its insiders, resulting in a net purchase of 2,417 shares.

Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avenue Therapeutics Inc Insider Transactions

No Available Data

Thomas Gregory Moore Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Gregory Moore. You might contact Thomas Gregory Moore via mailing address: C/o Akorn, Inc., 1925 West Field Court, Suite 300, Lake Forest Il 60045.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.